CDKN2A and neoplasm: Among the cases with ubiquitous strong expression in all tumour cells, there was also a variety in cellular distribution of p16INK4a from almost exclusively nuclear (3 cases, Figure 2F) to intense cytoplasmic and nuclear positivity (22 cases, Figure 2B and C).